AUROBINDO PHARMA
|
The Current P/S Ratio of AUROBINDO PHARMA is 3.06.
Share Price | ₹1,567.6 | Sep 13,2024 |
Market Cap | ₹91,046.2 Cr | |
Sales-TTM | ₹29,718.4 Cr | TTM-Consolidated Results |
Price/Sales | 3.06x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of AUROBINDO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹91,046.2 Cr] as on Sep 13,2024
(/) Sales [ ₹29,718.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.06x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '3.06 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/S Ratio of AUROBINDO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AUROBINDO PHARMA
PS Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.64x.
- AUROBINDO PHARMA 's operated at median p/e ratio of 1.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/e ratio peaked in Mar2024 at 2.2x.
- AUROBINDO PHARMA 's p/e ratio hit its five-year low in Mar2020 of 1.05x.
How does AUROBINDO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
AUROBINDO PHARMA | 29,718.4 | 3.06 | 91,046.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 49,208.8 | 9.04 | 444,825.0 |
CIPLA LTD | 26,139.1 | 5.13 | 133,996.0 |
DR REDDYS LABORATORIES LTD | 28,949.3 | 3.84 | 111,112.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 5.46 | 112,547.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 17.82 | 145,892.0 |
MANKIND PHARMA LTD | 10,649.6 | 9.40 | 100,111.0 |
TORRENT PHARMACEUTICALS LTD | 10,996.0 | 10.64 | 116,955.0 |
LUPIN LTD | 20,797.1 | 4.94 | 102,793.0 |
ABBOTT INDIA LTD | 5,927.5 | 10.60 | 62,819.1 |
ALKEM LABORATORIES LTD | 12,731.7 | 5.98 | 76,073.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AUROBINDO PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 3.06x |
Max industry PS | 17.82x |
Median industry PS | 5.98x |
Average industry PS | 7.81x |
You may also like the below Video Courses